LINE in the 13F filings
Lineage Cell Theraputics In · CUSIP 53566V106
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 6 Aug 2026
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 3 listed it in both
- Shares listed
- 13,948,795
- combined, among listed positions
- Reported value
- $602m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 9 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,690,217.
Managers listing LINE in Q2 2026
20 of 20 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 4,673,227 shares now+1,980,993
- Balyasny Asset Management LLCnew position · 503,615 shares now+503,615
- Hudson Bay Capital Management LPnew position · 185,053 shares now+185,053
- AllianceBernstein LPexisting position · 151,060 shares now+109,928
- Squarepoint Ops LLCnew position · 41,921 shares now+41,921
Reductions
- D1 Capital Partners LPexisting position · 4,736,312 shares now-2,665,917
- T. Rowe Price Associates Incexisting position · 429,203 shares now-372,112
- Millennium Management LLCexisting position · 64,572 shares now-299,496
- Baillie Gifford & Coexisting position · 2,274,996 shares now-280,127
- Renaissance Technologies LLCexisting position · 40,900 shares now-251,800
New positions and exits
New (5)
Exited (7)
- Artisan Partners LPwas $11m
- Man Group PLCwas $1.2m
- Brevan Howard Capital Management LPwas $461k
- Caxton Associates LLPwas $339k
- Arrowstreet Capital LPwas $313k
- Freestone Grove Partners LPwas $115k
- Quantbot Technologies LPwas $77k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 16 | $1.5bn | 16 | 0 |
| Q4 2024 | 12 | $1.1bn | 9 | 7 |
| Q1 2025 | 9 | $1.3bn | 6 | 3 |
| Q2 2025 | 11 | $1.0bn | 8 | 3 |
| Q3 2025 | 7 | $646m | 4 | 4 |
| Q4 2025 | 6 | $481m | 13 | 12 |
| Q1 2026 | 4 | $341m | 13 | 12 |
| Q2 2026 | 4 | $513m | 9 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LINE and WELL →LINE and EQIX →LINE and PLD →Choose a stock to compare with LINE →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LINE, latest filings →Back to the 13F Explorer →